213 related articles for article (PubMed ID: 28695555)
1. Adherence to osteoporosis pharmacotherapy one year after osteoporotic fracture - a Swiss trauma center secondary prevention project.
Morell S; Hemmeler C; Amsler F; Gross T
Swiss Med Wkly; 2017; 147():w14451. PubMed ID: 28695555
[TBL] [Abstract][Full Text] [Related]
2. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009.
Balasubramanian A; Tosi LL; Lane JM; Dirschl DR; Ho PR; O'Malley CD
J Bone Joint Surg Am; 2014 Apr; 96(7):e52. PubMed ID: 24695929
[TBL] [Abstract][Full Text] [Related]
3. Treatment and Management of Osteoporotic Fractures: A Nation-wide Survey of 484 Senior Orthopaedists in China.
Man Y; Pan W; Lu J; Li SY; Zhang P; Guo JZ; Yu SF; Zhang B; Xiao E; Zhang C; Zuo W; Jin HJ; Chen Y; Wu B; Shi XE; Hong D; Liu X; Gao YX; Li J; Yin L; Xue QY
Orthop Surg; 2016 Nov; 8(4):432-439. PubMed ID: 28032704
[TBL] [Abstract][Full Text] [Related]
4. Long-term persistence with anti-osteoporosis drugs after fracture.
Klop C; Welsing PM; Elders PJ; Overbeek JA; Souverein PC; Burden AM; van Onzenoort HA; Leufkens HG; Bijlsma JW; de Vries F
Osteoporos Int; 2015 Jun; 26(6):1831-40. PubMed ID: 25822104
[TBL] [Abstract][Full Text] [Related]
5. Secondary prevention of osteoporosis following fragility fractures of the distal radius in a large health maintenance organization.
Benzvi L; Gershon A; Lavi I; Wollstein R
Arch Osteoporos; 2016; 11():20. PubMed ID: 27142832
[TBL] [Abstract][Full Text] [Related]
6. Underutilization of antiosteoporotic drugs by orthopedic surgeons for prevention of a secondary osteoporotic fracture.
Iba K; Takada J; Hatakeyama N; Kaya M; Isogai S; Tsuda H; Obata H; Miyano S; Yamashita T
J Orthop Sci; 2006 Oct; 11(5):446-9. PubMed ID: 17013730
[TBL] [Abstract][Full Text] [Related]
7. Declining trend in osteoporosis management and screening following vertebral compression fractures - a national analysis of commercial insurance and medicare advantage beneficiaries.
Malik AT; Retchin S; Phillips FM; Xu W; Peters K; Yu E; Khan SN
Spine J; 2020 Apr; 20(4):538-546. PubMed ID: 31683068
[TBL] [Abstract][Full Text] [Related]
8. What is a reasonable rate for specific osteoporosis drug therapy in older fragility fracture patients?
Gosch M; Bail HJ; Grueninger S; Stumpf U; Kammerlander C; Wicklein S
Arch Osteoporos; 2020 Feb; 15(1):20. PubMed ID: 32088765
[TBL] [Abstract][Full Text] [Related]
9. Secondary prevention of osteoporotic fractures: evaluation of the Amiens University Hospital's fracture liaison service between January 2010 and December 2011.
Dehamchia-Rehailia N; Ursu D; Henry-Desailly I; Fardellone P; Paccou J
Osteoporos Int; 2014 Oct; 25(10):2409-16. PubMed ID: 24980182
[TBL] [Abstract][Full Text] [Related]
10. [Patient- vs Physician-Reported Implementation of and Compliance to Anti-Osteoporotic Medication One Year after Sustained Fragility Fracture].
Gross T
Praxis (Bern 1994); 2018; 107(11):573-584. PubMed ID: 29788846
[TBL] [Abstract][Full Text] [Related]
11. Prevention of osteoporotic refractures in regional Australia.
Davidson E; Seal A; Doyle Z; Fielding K; McGirr J
Aust J Rural Health; 2017 Dec; 25(6):362-368. PubMed ID: 28618161
[TBL] [Abstract][Full Text] [Related]
12. Use of antiosteoporotic drugs and calcium/vitamin D in patients with fragility fractures: impact on re-fracture and mortality risk.
Degli Esposti L; Girardi A; Saragoni S; Sella S; Andretta M; Rossini M; Giannini S;
Endocrine; 2019 May; 64(2):367-377. PubMed ID: 30515678
[TBL] [Abstract][Full Text] [Related]
13. [Primary and Secondary Prevention of Hip Fragility Fracture in Teruel Health Sector, Aragon, Spain].
Gómez Navarro R; González García P; Martín Hernández C; Castro Sauras Á; Valdearcos Enguídanos S
Rev Esp Salud Publica; 2017 Jan; 91():. PubMed ID: 28025971
[TBL] [Abstract][Full Text] [Related]
14. Secondary prevention of minor trauma fractures: the effects of a tailored intervention-an observational study.
van der Vet PCR; Kusen JQ; Rohner-Spengler M; Link BC; Houwert RM; Babst R; Henzen C; Schmid L; Beeres FJP
Arch Osteoporos; 2019 Mar; 14(1):44. PubMed ID: 30923963
[TBL] [Abstract][Full Text] [Related]
15. Compliance to The Joint Commission proposed Core Measure set on osteoporosis-associated fracture: review of different secondary fracture prevention programs in an open medical system from 2010 to 2015.
Fojas MC; Southerland LT; Phieffer LS; Stephens JA; Srivastava T; Ing SW
Arch Osteoporos; 2017 Dec; 12(1):16. PubMed ID: 28155141
[TBL] [Abstract][Full Text] [Related]
16. Low prevalence of osteoporosis treatment in patients with recurrent major osteoporotic fracture.
Flais J; Coiffier G; Le Noach J; Albert JD; Faccin M; Perdriger A; Thomazeau H; Guggenbuhl P
Arch Osteoporos; 2017 Dec; 12(1):24. PubMed ID: 28251468
[TBL] [Abstract][Full Text] [Related]
17. Two-year adherence to treatment and associated factors in a fracture liaison service in Spain.
Naranjo A; Ojeda-Bruno S; Bilbao-Cantarero A; Quevedo-Abeledo JC; Diaz-González BV; Rodríguez-Lozano C
Osteoporos Int; 2015 Nov; 26(11):2579-85. PubMed ID: 26048675
[TBL] [Abstract][Full Text] [Related]
18. Meeting international standards of secondary fracture prevention: a survey on Fracture Liaison Services in the Netherlands.
van den Berg P; Schweitzer DH; van Haard PM; van den Bergh JP; Geusens PP
Osteoporos Int; 2015 Sep; 26(9):2257-63. PubMed ID: 25860976
[TBL] [Abstract][Full Text] [Related]
19. Oral bisphosphonate prescription and non-adherence at 12 months in patients with hip fractures treated in an acute geriatric unit.
Gamboa A; Duaso E; Marimón P; Sandiumenge M; Escalante E; Lumbreras C; Tarrida A
Osteoporos Int; 2018 Oct; 29(10):2309-2314. PubMed ID: 30076454
[TBL] [Abstract][Full Text] [Related]
20. Divergent Patterns of Antifracture Medication Use Following Fracture on Therapy: A Population-Based Cohort Study.
Kline GA; Morin SN; Lix LM; Leslie WD
J Clin Endocrinol Metab; 2022 Jan; 107(2):491-499. PubMed ID: 34555165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
